CymaBay Therapeutics, Inc. (CBAY)
Q3 2018 Earnings Conference Call
November 6, 2018 4:30 PM ET
Executives
Dan Menold — Vice President-Finance
Sujal Shah — Chief Executive Officer
Pol Boudes — Chief Medical Officer
Chuck McWherter — Chief Scientific Officer
Analysts
Yasmeen Rahimi — Roth Capital
Jay Olson — Oppenheimer & Company
Joseph Schwartz — Leerink Partners
Steve Seedhouse — Raymond James
Tyler Van Buren — Piper Jaffray
Presentation
Operator
Good day, ladies and gentlemen, and welcome to CymaBay's Third Quarter 2018 Financial Results Conference Call. [Operator Instructions] Please be advised that the call will be